This award is presented to a small/diverse supplier that has shown continued growth for the past 3-5 years, helped life sciences clients overcome challenges, improved operations and service offerings, contributed to the community, and has supported other small/diverse businesses through B2B initiatives.

TRI has been honored to be included in the Top 10 CROs of 2019 by Pharma Tech Outlook. A panel of CEOs, CIOs, VCs, and analysts along with the editorial panel of Pharma Tech Outlook indexed these organizations.

TRI possesses all the essential resources to offer first-class functional, project-based, and full-service outsourcing services: quality operational, strategic, technical, and regulatory solutions, long-standing clinical trial expertise, and deep therapeutic knowledge.

We are more than a CRO. We offer a broad array of health communication services such as multi-level event planning and execution, design and implementation of marketing and outreach campaigns, multi-media design, focus groups, surveys, trainings, and product launches.

Investigational site quality cannot be achieved through monitoring alone. It has to be built into the site’s processes; therefore, we invest significant effort and time in helping our Investigators implement effective Quality Management Systems (QMS)